Risk factors for restenosis after percutaneous transluminal coronary angioplasty: Role of lipoprotein (a)
- 31 December 1995
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 130 (6) , 1168-1173
- https://doi.org/10.1016/0002-8703(95)90138-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease.Circulation, 1994
- The relationship between serum lipoprotein (a) and Restenosis after initial elective percutaneous transluminal coronary angioplasty.Japanese Circulation Journal, 1993
- Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty.Circulation, 1992
- Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1992
- Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participantsAtherosclerosis, 1991
- The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplastyJournal of the American College of Cardiology, 1991
- Lipoprotein(a), fibrin binding, and plasminogen activation.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.Circulation, 1989
- Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients.Circulation, 1988
- Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.Circulation, 1986